The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways

Cervical cancer is one of the most common and lethal cancers among women worldwide. Treatment options are limited in patients with persistent, recurrent, or metastatic cervical cancer, with <20% of women living >5 years. Persistent human papillomavirus (HPV) infection has been implicated in al...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Michael J. Birrer, Keiichi Fujiwara, Ana Oaknin, Leslie Randall, Laureen S. Ojalvo, Christian Valencia, Isabelle Ray-Coquard
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2022-02-01
Σειρά:	Frontiers in Oncology
Θέματα:	cervical cancer HPV tumor microenvironment TGF-β PD-L1
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fonc.2022.814169/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!